Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis

Mise à jour : Il y a 4 ans
Référence : NCT00812045

Femme et Homme

Extrait

The purpose of this study is to determine the effect of AZD1236 in patients with cystic fibrosis (CF) on inflammatory biomarkers in induced sputum, after a treatment period of 4 weeks.


Critère d'inclusion

  • Cystic fibrosis


Liens